Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Site Study Accessing the Acceptability and Feasibility of Patient-specific 'Tumouroids' as Personalised Treatment Screening Tools

NCT03300102 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03300102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03300102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Site Study Accessing the Acceptability and Feasibility of Patient-specific 'Tumouroids' as Personalised Treatment Screening Tools
Lead sponsor
University College, London
Phase
Observational
Overall status
Completed
Start date
January 10, 2018
Completion date
December 31, 2018
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer